AU3630997A - Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library for use in an anti-gg2 elisa - Google Patents

Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library for use in an anti-gg2 elisa

Info

Publication number
AU3630997A
AU3630997A AU36309/97A AU3630997A AU3630997A AU 3630997 A AU3630997 A AU 3630997A AU 36309/97 A AU36309/97 A AU 36309/97A AU 3630997 A AU3630997 A AU 3630997A AU 3630997 A AU3630997 A AU 3630997A
Authority
AU
Australia
Prior art keywords
hsv
glycoprotein
elisa
identification
display library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36309/97A
Inventor
Anna Marie Grabowska
William Lucien Irving
Peter Laing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Holding Ltd
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of AU3630997A publication Critical patent/AU3630997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/03Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/035Herpes simplex virus I or II

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU36309/97A 1996-07-24 1997-07-24 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library for use in an anti-gg2 elisa Abandoned AU3630997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9615533 1996-07-24
GBGB9615533.8A GB9615533D0 (en) 1996-07-24 1996-07-24 Diagnostic test for herpes simplex virus type-2
PCT/GB1997/002003 WO1998003544A1 (en) 1996-07-24 1997-07-24 IDENTIFICATION OF SHORT PEPTIDE SEQUENCES REPRESENTING EPITOPES OF GLYCOPROTEIN G OF HSV-2 USING A PHAGE PEPTIDE DISPLAY LIBRARY FOR USE IN AN ANTI-gG2 ELISA

Publications (1)

Publication Number Publication Date
AU3630997A true AU3630997A (en) 1998-02-10

Family

ID=10797426

Family Applications (2)

Application Number Title Priority Date Filing Date
AU36309/97A Abandoned AU3630997A (en) 1996-07-24 1997-07-24 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library for use in an anti-gg2 elisa
AU36301/97A Abandoned AU3630197A (en) 1996-07-24 1997-07-24 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU36301/97A Abandoned AU3630197A (en) 1996-07-24 1997-07-24 Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library

Country Status (3)

Country Link
AU (2) AU3630997A (en)
GB (1) GB9615533D0 (en)
WO (2) WO1998003544A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6417324B1 (en) 2000-04-21 2002-07-09 Tripep Ab Synthetic peptides that bind to the hepatitis B virus core and e antigens
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
GB2323360B (en) * 1997-01-14 1999-06-23 Medical Res Council Peptide structures and their use in diagnosis of herpes simplex virus type 2
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
US7318926B2 (en) 2003-02-06 2008-01-15 Tripep Ab Glycosylated specificity exchangers
US7267940B2 (en) * 2003-03-04 2007-09-11 Bio-Rad Laboratories, Inc. HSV-2 type-specific immunoassays using glycoprotein G2 peptides
JP2007526919A (en) * 2004-03-05 2007-09-20 バイオ−ラッド ラボラトリーズ,インコーポレイティド HSV-2 type specific immunoassay using glycoprotein G2 peptide
JP2007224043A (en) * 2007-04-18 2007-09-06 Medical Res Council Peptide structure and use of the same in diagnosis of herpes simplex virus type 2
RS62747B1 (en) 2016-02-01 2022-01-31 Simplexia Ab Truncated glycoprotein g of herpes simplex virus 2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
WO1991017443A1 (en) * 1990-05-04 1991-11-14 E.I. Du Pont De Nemours And Company A method of determining type specific antibodies to herpes simplex virus types 1 and 2
DE69534077T2 (en) * 1994-01-14 2005-08-11 Rath, Matthias, Dr.med. USE OF METHODS FOR IDENTIFYING HYDROPHILIC SIGNAL OLIGOPEPTIDES

Also Published As

Publication number Publication date
WO1998003544A1 (en) 1998-01-29
AU3630197A (en) 1998-02-10
WO1998003543A1 (en) 1998-01-29
GB9615533D0 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
ZA957989B (en) Antigen binding peptides (abtides) from peptide libraries
IL123258A0 (en) Opioid peptides
IL112903A0 (en) GnRH antagonist peptides
HUP9901455A3 (en) Somatostatin peptides
EP0701446A4 (en) Hemoregulatory peptides
GB9712892D0 (en) Identification of mhc binding peptides
AU3630997A (en) Identification of short peptide sequences representing epitopes of glycoprotein g of hsv-2 using a phage peptide display library for use in an anti-gg2 elisa
AP9400605A0 (en) New peptides
AU5849796A (en) Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
EP0826037A4 (en) Orpinomyces xylanase proteins and coding sequences
IL108353A0 (en) Novel peptides
DE69427363D1 (en) Platelet-inhibiting peptides
IL108509A0 (en) GnRH antagonist peptides
EP1029034A4 (en) Signal peptide containing proteins and uses therefor
IL116003A (en) Bradykinin antagonist peptides containing indane substituted amino acids
AU6397796A (en) Method for identifying peptides that affect protein-protein interactions and complement-modulating peptides
PL334877A1 (en) Peptides having their t-cell epitopes specific for collagen ii
GB9506372D0 (en) New peptide compounds
GB9519511D0 (en) Peptides
IL113441A0 (en) Opioid peptide analoog
EP0725651A4 (en) Hemoregulatory peptides
AU1487095A (en) Peptides for inhibiting pepsin release
GB9613705D0 (en) Novel peptides
EP0760376A4 (en) Peptides inhibiting phospholipase c
HU00722A9 (en) Isosteric peptides